Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 25,114	$ 269,480
Trade receivables, net of allowance of $2,805 and $3,394, respectively	195,192	169,350
Costs in excess of billings, net	(41,648)	(34,570)
Inventories, net	170,304	138,140
Prepaid expenses and other current assets	41,228	39,792
Total current assets	473,486	651,332
Property, plant, and equipment, net	128,671	109,820
Operating lease assets	56,712	45,021
Goodwill	594,620	507,419
Acquired intangibles	181,690	103,882
Other assets	4,239	1,936
Total assets	1,439,418	1,419,410
Current liabilities:
Accounts payable	137,970	117,408
Accrued expenses	98,428	95,664
Billings in excess of costs	40,230	41,790
Total current liabilities	276,628	254,862
Deferred income taxes	75,505	56,655
Non-current operating lease liabilities	46,317	35,125
Other non-current liabilities	31,630	24,734
Stockholders’ equity:
Preferred stock, $0.01 par value; authorized 10,000 shares; none outstanding	0	0
Common stock, $0.01 par value; authorized 100,000 shares; 34,401 and 34,313 shares issued and outstanding in 2025 and 2024	344	343
Additional paid-in capital	346,653	343,583
Retained earnings	896,970	875,851
Accumulated other comprehensive loss	(5,277)	(5,326)
Cost of 4,911 and 3,960 common shares held in treasury in 2025 and 2024	(229,352)	(166,417)
Total stockholders’ equity	1,009,338	1,048,034
Total liabilities and shareholders' equity	$ 1,439,418	$ 1,419,410